Changement de paradigme dans les thérapies ciblant les protéines membranaires - De la production d'antigènes à la validation des candidats

08:30 Registration and Participants welcome

09:00 Changing paradigm on membrane proteins as target for antibody discovery and validation: Case study | Dr. Rosie Dawaliby (CEO, G.CLIPS biotech)
10:00 Writing the future of biologics with an integrated offering of immunization, libraries, and machine learning | Dr. Radha Parmar (Twist Bioscience)

11:00 Coffee Break

11:15 The DNA engine that powers the bio-economy | Dr. Radha Parmar (Twist Bioscience)
11:35 Quality control and characterization of mAbs and ADCs by structural mass spectrometry | Dr. Julien Marcoux (IPBS)
12:05 Innovative biophysical methods for the characterization of macromolecules such as antibodies and ADCs conjugates | Dr. Virginie Nahoum (Head of PICT, Toulouse Integrated Screening Platform)

12:35 Closing remarks by Conference chair